Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087800 · ClinicalTrials.gov registry record
Smoking, Stress & Allopregnanolone Response
A clinical trial of Smoking Cessation, sponsored by University of Minnesota.
- Completed
- Registry status
- 43
- Enrollment target
- 1
- Study location
NCT02087800: Completed study of Smoking Cessation, sponsored by University of Minnesota.
NCT02087800 is a study of Smoking Cessation that has completed, run by University of Minnesota. The registered enrollment target is 43 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02087800, a study of Smoking Cessation, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.
Primary Outcome
The change in ALLO after delivery of the acute stressor will be analyzed.
Conditions Studied
Interventions
- BEHAVIORAL F phase lab session
- BEHAVIORAL L phase lab session
Study Locations (1)
Minnesota
- University of Minnesota Tobacco Research Program - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-08 |
What the finished NCT02087800 record still lists
NCT02087800 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which F phase lab session is the first listed.
NCT02087800 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02087800 about?
NCT02087800 is a clinical study titled "Smoking, Stress & Allopregnanolone Response". This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.
What is the current status of trial NCT02087800?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2014-04. Estimated completion is 2015-08.
What conditions does trial NCT02087800 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02087800?
The interventions under investigation include: F phase lab session (BEHAVIORAL), L phase lab session (BEHAVIORAL).
Who is sponsoring clinical trial NCT02087800?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087800 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02087800's enrollment target sits among peer trials
43 157th of 188 higher than 32 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia